#COVID19 #CoronaVirus #pharmaceuticals #CoronaPandemic #biospace #lifesciences #CoronaOutbreak #biotechnology #ArtificialIntelligence #stocks

Career And Jobs

On Apr 21, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: April 21 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/glsmdqNKIN

Open

Biopharma Update on the Novel Coronavirus: April 21

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 21, 2020.

On Apr 23, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: April 23 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/BDwTGXEI2V

Open

Biopharma Update on the Novel Coronavirus: April 23

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 23, 2020.

On Apr 22, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: April 22 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/TNrDT9wXnP

Open

Biopharma Update on the Novel Coronavirus: April 22

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 22, 2020.

On Apr 21, 2020

@GENbio shared

#ArtificialIntelligence Is Helping Biotech Get Real -- https://t.co/kgVkBNgbYB https://t.co/evRO21ifi9

Open

Artificial Intelligence Is Helping Biotech Get Real

www.genengnews.com

No longer the stuff of fantasy, AI is entering the real world everywhere—biotech included. AI’s biotech applications include drug target identification, drug screening, and the analysis of ...

On Apr 21, 2020

@Labiotech_eu shared

While #biotech #stocks will certainly hit rough times in the short run, the positive outcomes of the situation may be promising in the years to come. 🚀#coronavirus #Covid19 https://t.co/hpd1Ymy80z

Open

Analysis: How has Coronavirus Affected Europe’s Biotech Stocks?

www.labiotech.eu

The information flow about the coronavirus pandemic is truly electrifying, with big public market swings in the life sciences industry. That said, exactly what sort of impact is the disease ...

On Apr 23, 2020

@MassBio shared

As priorities shift in response to #COVID19, @EdieStringfello reached out to a few MassBio members to find out if & how they were able to pivot their ED&I strategies to respond to our shared “New Normal.” Here is what they had to say: https://t.co/PiQgwHvEPN #PathToDiversity https://t.co/rCEalcyyMx

Open

Impact of the “New Normal” on ED&I Strategies in BioPharma

www.massbio.org

However, as priorities shift in response to COVID-19 and the related impacts on work and workforce, I reached out to a few MassBio member organizations to find out if and how they were able ...

On Apr 21, 2020

@BioWorld shared

Swiss biotech investment slipped 25% in 2019 as sector braced for COVID-19 disruption https://t.co/40Lp0MRY4R

Open

Swiss biotech investment slipped 25% in 2019 as sector braced for COVID-19 disruption

www.bioworld.com

DUBLIN – The Swiss biotech sector raised about CHF1.2 billion ($$1.2 billion) in equity investment in 2019, a significant downward dip on the last two years, but well ahead of its average ...

On Apr 27, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: April 27 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/4UizwwWcsC

Open